A Clinical Study on the Efficacy and Safety of Fruquintinib in Combination With PD-1 Monoclonal Antibody and Chidamide in Refractory MSS Metastatic Colorectal Cancer
Clinical trial NCT06979908 · RECRUITING
Trial details
- NCT number
- NCT06979908
- Sponsor
- The First Hospital of Jilin University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-22
- Primary completion
- 2026-07-22
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.